International Clinical Trials Day: Consent, technology and participation barriers, with Dr Rebecca Saunderson

Welcome to another OpylPd, continuing our series in celebration of International Clinical Trials Day last Saturday.

Opyl CEO Michelle Gallaher recently spoke to Dr Rebecca Saunderson, founder and CEO of Consentic - a start-up making waves with new technologies that streamline consent in health research.  They discuss all things process, intelligent technology and the evolving participant experience in clinical studies.

Enjoy!